TUDOR INVESTMENT CORP ET AL - SAGENT PHARMACEUTICALS INC ownership

SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 114 filers reported holding SAGENT PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$142,000
-65.5%
11,664
-54.8%
0.00%
-66.7%
Q4 2015$411,000
-25.5%
25,829
+13.8%
0.01%
-25.0%
Q2 2015$552,000
+99.3%
22,692
+90.7%
0.02%
+77.8%
Q1 2015$277,000
-59.0%
11,900
-55.8%
0.01%
-60.9%
Q4 2014$675,000
+70.9%
26,900
+111.8%
0.02%
+64.3%
Q3 2014$395,000
-16.1%
12,700
-30.2%
0.01%
-22.2%
Q2 2014$471,00018,2000.02%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Timpani Capital Management LLC 110,215$2,248,0001.32%
Healthcare Value Capital, LLC 73,822$1,506,0001.32%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,014,863$20,703,0000.96%
Perimeter Capital Partners, LLC 248,893$5,077,0000.94%
Tekla Capital Management LLC 270,031$5,509,0000.61%
SECTORAL ASSET MANAGEMENT INC 564,325$11,512,0000.55%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 168,268$3,432,0000.35%
MENTA CAPITAL LLC 30,480$622,0000.32%
KOPP INVESTMENT ADVISORS LLC 39,934$815,0000.30%
Broadfin Capital, LLC 68,300$1,393,0000.25%
View complete list of SAGENT PHARMACEUTICALS INC shareholders